Clinical trial

Optimization of Treatment and Management of Schizophrenia in Europe

NCT01248195

Drugs and interventions used in this trial

5 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Amisulpride open label Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention 6-week amisulpride double blind treatment Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention 6-week olanzapine double blind treatment Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention 12-week clozapine open-label treatment Find medicine records · Find other trials using this name

BEHAVIORAL · Unmapped registry intervention Psychosocial intervention Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Optimization of Treatment and Management of Schizophrenia in Europe

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE4

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2011-05-01

PhasePHASE4

Conditions

Schizophreniaverified · MONDO: schizophrenia

Schizophreniform Disorderverified · MONDO: schizophreniform disorder

Schizoaffective Disorderverified · MONDO: schizoaffective disorder

Interventions

Amisulpride open labelDRUG

6-week amisulpride double blind treatmentDRUG

6-week olanzapine double blind treatmentDRUG

12-week clozapine open-label treatmentDRUG

Psychosocial interventionBEHAVIORAL

Sponsors & collaborators

Rene Kahnlead sponsor

King's College Londoncollaborator

Technical University of Munichcollaborator

University of Manchestercollaborator

Ludwig-Maximilians - University of Munichcollaborator

Mapped research locations

MadridSpain3 LondonUnited Kingdom2 MünchenGermany2 BarcelonaSpain1 ManchesterUnited Kingdom1 LeuvenBelgium1 BucharestRomania1 SofiaBulgaria1 NaplesItaly1 PoznanPoland1 CréteilFrance1 UtrechtNetherlands1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01248195 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.